Personal health and wellness is one of the many secular tailwinds for healthcare companies. Despite the rosy long-term ...

Pacific Biosciences of California, Inc. PACB, popularly known as PacBio, delivered an adjusted loss per share of 20 cents in fourth-quarter 2024, narrower than the year-ago adjusted loss of 27 ...

PACB ended the quarter with 270 cumulative Revio ... These look promising for the stock. Yet, the continued loss per share reported by PacBio was disappointing. The year-over-year fall in the ...

New York State Common Retirement Fund raised its holdings in shares of Pacific Biosciences of California, Inc. (NASDAQ:PACB – ...

Pacific Biosciences of California, Inc. PACB, popularly known as PacBio, delivered an adjusted loss per share of 20 cents in fourth-quarter 2024, narrower than the year-ago adjusted loss of 27 cents ...

10 Stocks to Sell NOW! 3 Stocks to DOUBLE This Year The 10 Best Stocks to Own in 2023 7 Stocks to Buy and Hold Forever PACB stock opened at $1.56 on Tuesday. Pacific Biosciences of California has ...

Bernstein analyst Eve Burstein maintained a Buy rating on Pacific Biosciences (PACB – Research Report) today and set a price target of $2.00.

Pacific Biosciences of California (PACB) came out with a quarterly loss ... The sustainability of the stock's immediate price movement based on the recently-released numbers and future earnings ...

Growth in clinical and diagnostic markets will help, but not right away, and PACB is likely to remain below ... near-term research funding, and the stock is basically a high-risk, binary investment.